Cargando…
Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases
Bone metastases from prostate cancer (PCa) result from a complex cross-talk between PCa cells and osteoblasts (OB). Thus, targeting this interplay has become an attractive strategy to interfere with PCa bone dissemination. The agents currently used in clinical trials have proved ineffective, boostin...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508123/ https://www.ncbi.nlm.nih.gov/pubmed/34638532 http://dx.doi.org/10.3390/ijms221910191 |
_version_ | 1784582022221529088 |
---|---|
author | Antognelli, Cinzia Marinucci, Lorella Frosini, Roberta Macchioni, Lara Talesa, Vincenzo Nicola |
author_facet | Antognelli, Cinzia Marinucci, Lorella Frosini, Roberta Macchioni, Lara Talesa, Vincenzo Nicola |
author_sort | Antognelli, Cinzia |
collection | PubMed |
description | Bone metastases from prostate cancer (PCa) result from a complex cross-talk between PCa cells and osteoblasts (OB). Thus, targeting this interplay has become an attractive strategy to interfere with PCa bone dissemination. The agents currently used in clinical trials have proved ineffective, boosting research to identify additional mechanisms that may be involved in this two-directional talk. Here, we investigated whether and how 5-hydro-5-methylimidazolone (MG-H1), a specific methylglyoxal (MG)-derived advanced glycation end product (AGE), was a novel player in the dialogue between PCa and OB to drive PCa bone metastases. Conditioned medium from osteotropic PC3 PCa cells, pre-treated or not with a specific MG scavenger, was administrated to human primary OB and cell morphology, mesenchymal trans-differentiation, pro-osteogenic determinants, PCa-specific molecules, and migration/invasion were studied by phase-contrast microscopy, real-time PCR, western blot and specific assays, respectively. We found that PC3 cells were able to release MG-H1 that, by binding to the receptor for AGEs (RAGE) on OB, reprogrammed them into a less-differentiate phenotype, endowed with some PCa-specific molecular features and malignant properties, in a mechanism involving reactive oxidative species (ROS) production and NF-kB pathway activation. These findings provide novel insights into the mechanisms of PCa osteoblastic metastases and foster in vivo research toward new therapeutic strategies interfering with PCa/OB cross-talk. |
format | Online Article Text |
id | pubmed-8508123 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85081232021-10-13 Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases Antognelli, Cinzia Marinucci, Lorella Frosini, Roberta Macchioni, Lara Talesa, Vincenzo Nicola Int J Mol Sci Article Bone metastases from prostate cancer (PCa) result from a complex cross-talk between PCa cells and osteoblasts (OB). Thus, targeting this interplay has become an attractive strategy to interfere with PCa bone dissemination. The agents currently used in clinical trials have proved ineffective, boosting research to identify additional mechanisms that may be involved in this two-directional talk. Here, we investigated whether and how 5-hydro-5-methylimidazolone (MG-H1), a specific methylglyoxal (MG)-derived advanced glycation end product (AGE), was a novel player in the dialogue between PCa and OB to drive PCa bone metastases. Conditioned medium from osteotropic PC3 PCa cells, pre-treated or not with a specific MG scavenger, was administrated to human primary OB and cell morphology, mesenchymal trans-differentiation, pro-osteogenic determinants, PCa-specific molecules, and migration/invasion were studied by phase-contrast microscopy, real-time PCR, western blot and specific assays, respectively. We found that PC3 cells were able to release MG-H1 that, by binding to the receptor for AGEs (RAGE) on OB, reprogrammed them into a less-differentiate phenotype, endowed with some PCa-specific molecular features and malignant properties, in a mechanism involving reactive oxidative species (ROS) production and NF-kB pathway activation. These findings provide novel insights into the mechanisms of PCa osteoblastic metastases and foster in vivo research toward new therapeutic strategies interfering with PCa/OB cross-talk. MDPI 2021-09-22 /pmc/articles/PMC8508123/ /pubmed/34638532 http://dx.doi.org/10.3390/ijms221910191 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Antognelli, Cinzia Marinucci, Lorella Frosini, Roberta Macchioni, Lara Talesa, Vincenzo Nicola Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases |
title | Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases |
title_full | Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases |
title_fullStr | Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases |
title_full_unstemmed | Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases |
title_short | Metastatic Prostate Cancer Cells Secrete Methylglyoxal-Derived MG-H1 to Reprogram Human Osteoblasts into a Dedifferentiated, Malignant-like Phenotype: A Possible Novel Player in Prostate Cancer Bone Metastases |
title_sort | metastatic prostate cancer cells secrete methylglyoxal-derived mg-h1 to reprogram human osteoblasts into a dedifferentiated, malignant-like phenotype: a possible novel player in prostate cancer bone metastases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508123/ https://www.ncbi.nlm.nih.gov/pubmed/34638532 http://dx.doi.org/10.3390/ijms221910191 |
work_keys_str_mv | AT antognellicinzia metastaticprostatecancercellssecretemethylglyoxalderivedmgh1toreprogramhumanosteoblastsintoadedifferentiatedmalignantlikephenotypeapossiblenovelplayerinprostatecancerbonemetastases AT marinuccilorella metastaticprostatecancercellssecretemethylglyoxalderivedmgh1toreprogramhumanosteoblastsintoadedifferentiatedmalignantlikephenotypeapossiblenovelplayerinprostatecancerbonemetastases AT frosiniroberta metastaticprostatecancercellssecretemethylglyoxalderivedmgh1toreprogramhumanosteoblastsintoadedifferentiatedmalignantlikephenotypeapossiblenovelplayerinprostatecancerbonemetastases AT macchionilara metastaticprostatecancercellssecretemethylglyoxalderivedmgh1toreprogramhumanosteoblastsintoadedifferentiatedmalignantlikephenotypeapossiblenovelplayerinprostatecancerbonemetastases AT talesavincenzonicola metastaticprostatecancercellssecretemethylglyoxalderivedmgh1toreprogramhumanosteoblastsintoadedifferentiatedmalignantlikephenotypeapossiblenovelplayerinprostatecancerbonemetastases |